Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Korro Bio (KRRO) is now available.
David L. Lucchino resigned from our Board of Directors on August 26, 2024, but will stay connected as a strategic advisor under a consulting agreement until potentially 2027, with compensation details outlined. Simultaneously, the Board underwent restructuring, reducing and then increasing its size to appoint Dr. Katharine Knobil to a newly created position. Dr. Knobil will serve on the Board and Compensation Committee with a standard compensation and indemnification agreement, without any conflicts of interest regarding her appointment.
For detailed information about KRRO stock, go to TipRanks’ Stock Analysis page.
